ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links1 made here, not in the record5 judgments2 judges (the rules as one: Rule based)2 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older versionMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06422546A Prospective ,Multicenter,Non-interventional,Real-world Study ObservingChanges in MolecularMarkers OsimertinibTargeted Therapy in EGFRmNSCLCBeijing Cancer Prevention & TrrecruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 2 · ClinicalTrials.gov record · Version of 2026-11-02Nov 6 · ClinicalTrials.gov record · Version of 2026-11-06Nov 6 · Rule based · Reading set asideNov 18 · Rule based · Reading keptReading keptCONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSOsimertinibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ExposureNov 19 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Osimertinib

Made here2 judgments on this link
NCT06422546gives it, found by reading the recordOsimertinibDefined by Claude Opus 5.5Nov 3, 2026, 7:06 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Exposure
Exposure · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2The record itselfClinicalTrials.gov recordVersion of 2026-11-02Record change
Nov 3Osimertinibmade hereClaude Opus 5.5ExposureReplaced
Nov 6The record itselfClinicalTrials.gov recordVersion of 2026-11-06Record change
Nov 6The record itselfRule based · nightly checkReading set asideCurrent
Nov 18The record itselfRule based · nightly checkReading keptCurrent
Nov 19Osimertinibmade hereClaude Opus 5.5ExposureDraft
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.